MercachemSyncom closes acquisition of Alcami Weert
It is our great pleasure to announce today that MercachemSyncom has acquired Alcami’s European cGMP CMC drug substance development site, based in Weert, the Netherlands.
It is our great pleasure to announce today that MercachemSyncom has acquired Alcami’s European cGMP CMC drug substance development site, based in Weert, the Netherlands.
